Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
MSFT -7.97META 2.815BKNG 0.45HMP.TO 0SPGP 0.19ZUQ.TO -0.34NVDA -3.89GL 0.93
Valeant Pharmaceuticals (VRX.TO)

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 04, 2002
Model price is $45/47. Could drop further.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$39.20

Stock price when the opinion was issued

Healthcare
Track your Stocks in your Watch List
BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 03, 2002
An Agressive company. Patent litigations are are in progress. Volatile. Good price.
Photo of David BaskinDavid BaskinUnlock Rating
$38.50

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 02, 2002
High valuation.
Photo of Richard StoneRichard StoneUnlock Rating
$38.64

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 02, 2002
Prefers the bigger US companies.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$38.64

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 28, 2002
Likes. Well run. Good management.
Photo of Ted MacklinTed MacklinUnlock Rating
$44.66

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 27, 2002
Good entry point. Some risks.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$43.69

Stock price when the opinion was issued

Healthcare
STRONG BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 07, 2002
Very positive on this company. Good acquisitions. Good yield.
Photo of David CockfieldDavid CockfieldUnlock Rating
$48.16

Stock price when the opinion was issued

Healthcare
WAIT

Valeant Pharmaceuticals(VRX.TO)

Jun 06, 2002
Has potential to move higher, but there is risk in the short term. Management changes.
Photo of John ZechnerJohn ZechnerUnlock Rating
$9.15

Stock price when the opinion was issued

Healthcare
Track your Stocks in your Watch List
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 06, 2002
Have good drugs.
Photo of John ZechnerJohn ZechnerUnlock Rating
$48.35

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 05, 2002
Bought some on weakness. Good company/management teams. Not for the faint of heart.
Photo of Ted MacklinTed MacklinUnlock Rating
$47.99

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 04, 2002
Biotech group has been hit. Some accounting concerns which are minor. At a good price.
Photo of Ray SteeleRay SteeleUnlock Rating
$46.00

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 03, 2002
Affected by the biotech sector. A cloud is on it re the management.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$46.34

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jun 03, 2002
Has consistantly delivered 35% earnings growth.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$46.34

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

May 31, 2002
Drug stocks have dropped. Is not the leader.
Photo of David BurrowsDavid BurrowsUnlock Rating
$49.75

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

May 31, 2002
Comfortable with their forcast. Good products. Well organized.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$49.75

Stock price when the opinion was issued

Healthcare
Showing 616 to 630 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

FCX -0.2$69.93
MU -41.09$1046.9
WDC 45.93$699.46
AAPL 2.53$298.95
SPCX 23.15$215.65

Today's Top Picks

MSFT -7.97$391.79
META 2.815$596.295
BKNG 0.45$175.09
HMP.TO 0$9.76
SPGP 0.19$121.79

Popular Articles

Latest Sell Signals

CRWD -11.56$681.35
MSFT -7.97$391.79
SCCO -0.2$193.02
ADBE 1.82$208.18
PEP 0.195$146.445

Most Recent Experts

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica